PALIPERIDONE — all Canadian products
9 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is PALIPERIDONE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02300273 | INVEGA | JANSSEN INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 3 MG | Marketed | |
| 02300281 | INVEGA | JANSSEN INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 6 MG | Marketed | |
| 02300303 | INVEGA | JANSSEN INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 9 MG | Marketed | |
| 02300311 | INVEGA | JANSSEN INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 12 MG | Cancelled Pre Market | |
| 02511037 | MAR-PALIPERIDONE | MARCAN PHARMACEUTICALS INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 9 MG | Cancelled Pre Market | |
| 02511010 | MAR-PALIPERIDONE | MARCAN PHARMACEUTICALS INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 3 MG | Cancelled Post Market | |
| 02511029 | MAR-PALIPERIDONE | MARCAN PHARMACEUTICALS INC | Tablet (Extended-Release) | Oral | PALIPERIDONE 6 MG | Cancelled Post Market | |
| 02456400 | MYLAN-PALIPERIDONE | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | Oral | PALIPERIDONE 3 MG | Cancelled Pre Market | |
| 02437139 | MYLAN-PALIPERIDONE | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | Oral | PALIPERIDONE 6 MG | Cancelled Pre Market |
Browse other molecules: